Mirae Asset Global Investments
ARNA

Mirae Asset Global Investments’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Mirae Asset Global Investments’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,098
Closed -$244K – 1815
2021
Q3 		$244K Buy
4,098
+630
+18% +$37.2K ﹤0.01% 1653
2021
Q2 		$236K Buy
+3,468
New +$226K ﹤0.01% 1621
2017
Q4 		– Sell
-88,572
Closed -$2.26M – 724
2017
Q3 		$2.26M Sell
88,572
-14,494
-14% -$332K 0.04% 307
2017
Q2 		$1.74M Buy
+103,066
New +$1.41M 0.03% 331

Other funds holding ARNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Mirae Asset Global Investments's ARNA Position: Q4 2021 in Review

Mirae Asset Global Investments sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2021, closing a stake of 4,098 shares — an estimated $244K sold.

Mirae Asset Global Investments first reported a position in ARNA in Q2 2017 and held it in 4 quarters. The position peaked at $2.26M in Q3 2017. 316 funds tracked by Wall St. Rank hold ARNA as of Q4 2021.

  • Mirae Asset Global Investments reported no remaining Arena Pharmaceuticals Inc position as of Q4 2021 after selling out during the quarter.
  • Mirae Asset Global Investments sold 4,098 Arena Pharmaceuticals Inc shares in Q4 2021, an estimated $244K.
  • Mirae Asset Global Investments first reported a position in Arena Pharmaceuticals Inc in Q2 2017 and held it in 4 quarters.
  • Mirae Asset Global Investments's Arena Pharmaceuticals Inc position peaked at $2.26M in Q3 2017.
  • 316 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2021.

Based on Mirae Asset Global Investments's 13F filing for Q4 2021, filed 8 Feb 2022.